Lawrence Yuen

Lawrence Yuen

Auto-generated profile, based on publicly available information

Lawrence Yuen

Faculty of Medicine and Health Sciences, The University of Sydney, Sydney, NSW 2050, Australia

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Cancer Letters
Verified
Journal Article
Closed access
GZGang Zhou
Gang Zhou
SBSarah Da Won Bae
Sarah Da Won Bae
RNRomario Nguyen
Romario Nguyen
XHXiaoqi Huo
Xiaoqi Huo
SHShuanglin Han
Shuanglin Han
JGJacob George
Jacob George

7 February 2024 in Cancers
Verified
Journal Article
Open access
PDF file
RPRishaan Pawaskar
Rishaan Pawaskar
KHKevin Zhang Huang
Kevin Zhang Huang
HPHelen Pham
Helen Pham
ANAdnan Nagrial
Adnan Nagrial
MWMark Wong
Mark Wong
CNChristopher B Nahm
Christopher B Nahm
Perihilar cholangiocarcinoma (pCCA) is an uncommon malignancy with generally poor prognosis. Surgery is the primary curative treatment; however, the perioperative mortality and morbidity rates are high, with a low 5-year survival rate. Use of preoperative prognostic biomarkers to predict survival outcomes after surgery for pCCA are not well-established currently. This systematic review aimed to identify and summarise preoperative biomarkers associated with survival in pCCA, thereby potentially improving treatment decision-making. The Embase, Medline, and Cochrane databases were searched, and a systematic review was performed using the PRISMA guidelines. English-language studies examining the association between serum and/or tissue-derived biomarkers in pCCA and overall and/or disease-free survival were included. Our systematic review identified 64 biomarkers across 48 relevant studies. Raised serum CA19-9, bilirubin, CEA, neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and tumour MMP9, and low serum albumin were most associated with poorer survival; however, the cutoff values used widely varied. Several promising molecular markers with prognostic significance were also identified, including tumour HMGA2, MUC5AC/6, IDH1, PIWIL2, and DNA index. In conclusion, several biomarkers have been identified in serum and tumour specimens that prognosticate overall and disease-free survival after pCCA resection. These, however, require external validation in large cohort studies and/or in preoperatively obtained specimens, especially tissue biopsy, to recommend their use.

Verified
Journal Article
Open access
PDF file
FSFatema Safri
Fatema Safri
RPRussell Pickford
Russell Pickford
YXYikun Xu
Yikun Xu
WYWilliam Yang
William Yang
RNRomario Nguyen
Romario Nguyen
LQLiang Qiao
Liang Qiao
Metabolic dysfunction-associated fatty liver disease (MAFLD) is now the leading cause of hepatocellular carcinoma (HCC) globally. HCC surveillance is currently restricted to patients with cirrhosis, leaving those without cirrhosis, who present with more advanced disease and poorer outcomes without adequate risk stratification tools. This study compared lipid profiles across MAFLD and MAFLD-related HCC (MAFLD-HCC) patients, with and without cirrhosis, to characterise metabolic dysregulation underlying non-cirrhotic MAFLD-HCC (ncMAFLD-HCC). Plasma and liver lipidomic profiles were obtained from 221 patients (140 MAFLD, 66 cirrhotic MAFLD-HCC (cMAFLD-HCC), and 15 ncMAFLD-HCC) using untargeted liquid chromatography mass spectrometry. Univariate, multivariable and enrichment analyses were performed for statistically determining the lipid profile difference between the groups. Seventy percent of lipid classes were more abundant in MAFLD than in ncMAFLD-HCC and cMAFLD-HCC. Multivariate analysis revealed distinct lipid profiles across the three groups in both plasma and liver. Over 100 lipid species including diglyceride (DAG), sphingomyelin (SM), triglyceride (TG), dihydroceramide (DHCer), and linoleic acid derivatives were differentially expressed in ncMAFLD-HCC versus MAFLD, with enrichment in pathways such as glycerolipid metabolism, G-protein signalling, MAPK signalling, EGFR-TKI resistance pathway, implicated in HCC development. ncMAFLD-HCC exhibits a distinct lipid signature, offering preliminary mechanistic insight and a foundation for non-invasive biomarker development.

1 November 1991 in Experimental Physiology
Verified
Journal Article
Open access
PDF file
GPGg Pinter
Gg Pinter
SLSl Lightman
Sl Lightman
PWPd Wilson
Pd Wilson
LYL Yuen
L Yuen
MBMw Bradbury
Mw Bradbury
Diabetes was induced with streptozotocin in rats weighing about 160 g. These were maintained with age-matched controls for up to 14 months, blood glucose being periodically monitored. Half the diabetic and control rats received the aldose reductase inhibitor, Ponalrestat, in their diet. Distribution of volumes of 131I-albumin (5 min) and 125I-albumin (100 min) were estimated in various tissues at 3 weeks, 6-7 months and 13-14 months of diabetes. The former space was assumed to represent the intravascular plasma space, while the latter was taken to include both the extravascular and intravascular albumin volumes in the kidney. In heart and skeletal muscle, equilibration between the specific activities of extravascular albumin and of plasma albumin was not assumed to be complete at 100 min. In the cortex and medulla of kidney, the extravascular albumin pool increased significantly at 13-14 months of diabetes (for both, P less than 0.01). Significantly increased entry of albumin into the interstitium occurred at 6 months (P less than 0.05) and at 13-14 months (P less than 0.01) in skeletal muscle, and at 13-14 months (P less than 0.05) in heart. The intravascular plasma volumes were not influenced by diabetes and the aldose reductase inhibitor had no effect at any time in either diabetic or control rats. These findings indicate increased movement of plasma albumin into the interstitium in the late phase of diabetes in the heart, skeletal muscle and in the kidney. Enlargement of the interstitial albumin pool is likely to affect the fluid balance between capillary and interstitium and may contribute to the effect of diabetes on the function of these organs.

9 November 2021 in Anz Journal of Surgery
Verified
Journal Article
Closed access
PDF file
LTLinda Tang
Linda Tang
TLTaina Lee
Taina Lee
LYLawrence Yuen
Lawrence Yuen
HPHenry Pleass
Henry Pleass

2 July 2026 in Transplantation Direct
Verified
Journal Article
Open access
AHAmy Hort
Amy Hort
SPSwe Zin Phyoe
Swe Zin Phyoe
AHAhmer Hameed
Ahmer Hameed
TLTaina Lee
Taina Lee
PYPeter Yoon
Peter Yoon
HPHenry Pleass
Henry Pleass
Background.: Simultaneous pancreas–kidney transplantation (SPK) is the optimal treatment for selected patients with type I diabetes mellitus (T1DM) and end-stage kidney disease, but intraoperative bleeding remains a major cause of morbidity. Methylene blue flush during back-table pancreas preparation may better help preemptively identify bleeding points and reduce complications. Methods.: A single-center, single-blinded, prospective randomized control trial was conducted at Westmead Hospital over 30 mo. Sixty participants were randomized to receive either crystalloid (n = 33) or methylene blue (MB) flush (n = 27) during pancreas preparation before implantation. The primary outcome was intraoperative bleeding. Results.: There was no significant difference in intraoperative blood loss with the use of MB flush (433 ± 385 mL versus 588 ± 382 mL; P = 0.10). The MB group required significantly lower intraoperative blood transfusions (7% versus 27%, P = 0.032) but higher postoperative transfusions within 7 d (81% versus 58%, P = 0.038). No significant differences were observed in length of stay, reoperation rates, delayed graft function, readmission rates, graft loss, or mortality. Early graft loss and pancreatectomy were lower in the MB group (4% versus 12%) without reaching statistical significance ( P = 0.206). Conclusions.: MB flush did not significantly reduce intraoperative blood loss but reduced intraoperative transfusion requirements, while increasing postoperative blood transfusion requirements, indicating a temporal shift in bleeding pattern. Graft outcomes were unaffected. Further studies should explore mechanisms and evaluate long-term outcomes.